US6960439B2
(en)
|
1999-06-28 |
2005-11-01 |
Source Precision Medicine, Inc. |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
|
EP1198585B1
(de)
*
|
1999-06-28 |
2007-06-13 |
Source Precision Medicine, Inc. |
Verfahren zum Charakterisieren von biologischen Bedingungen, die kalibrierte Genexpressionsprofile verwenden
|
US6958225B2
(en)
|
1999-10-27 |
2005-10-25 |
Affymetrix, Inc. |
Complexity management of genomic DNA
|
CA2388511A1
(en)
*
|
1999-11-04 |
2001-05-10 |
Incyte Genomics, Inc. |
Tissue specific genes of diagnostic import
|
AU1466001A
(en)
*
|
1999-11-05 |
2001-05-14 |
Phase-1 Molecular Toxicology |
Methods of determining individual hypersensitivity to an agent
|
US6372431B1
(en)
*
|
1999-11-19 |
2002-04-16 |
Incyte Genomics, Inc. |
Mammalian toxicological response markers
|
GB2396351B
(en)
*
|
2000-02-04 |
2004-08-25 |
Aeomica Inc |
Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung
|
WO2001057251A2
(en)
*
|
2000-02-04 |
2001-08-09 |
Aeomica, Inc. |
Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
|
GB2396352B
(en)
*
|
2000-02-04 |
2004-08-25 |
Aeomica Inc |
Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow
|
US6884578B2
(en)
*
|
2000-03-31 |
2005-04-26 |
Affymetrix, Inc. |
Genes differentially expressed in secretory versus proliferative endometrium
|
WO2001084149A2
(en)
|
2000-04-29 |
2001-11-08 |
University Of Iowa Research Foundation |
Diagnostics and therapeutics for macular degeneration-related disorders
|
US20020012905A1
(en)
*
|
2000-06-14 |
2002-01-31 |
Snodgrass H. Ralph |
Toxicity typing using liver stem cells
|
DE10048633A1
(de)
*
|
2000-09-25 |
2002-04-18 |
Schering Ag |
Methode zur in vitro Diagnostik von Endometriose
|
US6780594B2
(en)
|
2000-09-25 |
2004-08-24 |
Schering Aktiengesellschaft |
Method for in vitro diagnosis of endometriosis
|
WO2002027321A2
(en)
|
2000-09-26 |
2002-04-04 |
Health Research Incorporated |
Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients
|
US7135278B1
(en)
|
2000-09-29 |
2006-11-14 |
University Of Rochester |
Method of screening for therapeutics for infectious diseases
|
WO2002057414A2
(en)
*
|
2000-10-20 |
2002-07-25 |
Expression Diagnostics, Inc. |
Leukocyte expression profiling
|
WO2003008647A2
(en)
*
|
2000-11-28 |
2003-01-30 |
University Of Cincinnati |
Blood assessment of injury
|
US20020142328A1
(en)
*
|
2000-12-01 |
2002-10-03 |
Danenberg Kathleen D. |
Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors
|
US7341717B2
(en)
*
|
2001-04-13 |
2008-03-11 |
Gpc Biotech Ag |
Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor
|
EP1385999B1
(de)
*
|
2001-04-30 |
2012-12-12 |
Ventana Medical Systems, Inc. |
Automatisiertes in situ oder mikroarray hybridisierungsverfahren und reagenzien dafür
|
US6905827B2
(en)
*
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
US7026121B1
(en)
*
|
2001-06-08 |
2006-04-11 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
CA2356540A1
(en)
*
|
2001-08-30 |
2003-02-28 |
Emory University |
Expressed dna sequences involved in mitochondrial functions
|
JP2005515757A
(ja)
*
|
2001-08-30 |
2005-06-02 |
エモリー・ユニバーシティ |
ミトコンドリア生物学発現アレイ
|
US20030068621A1
(en)
*
|
2001-10-04 |
2003-04-10 |
Jonathan Briggs |
Method and device for producing oligonucleotide arrays
|
EP1451340B1
(de)
|
2001-11-09 |
2014-01-08 |
Life Technologies Corporation |
Identifizierung, überwachung und behandlung einer krankheit sowie charakterisierung eines biologischen zustands unter verwendung von genexpressionsprofilen
|
WO2003053586A1
(en)
*
|
2001-12-19 |
2003-07-03 |
Affymetrix, Inc. |
Array plates and method for constructing array plates
|
US7504215B2
(en)
|
2002-07-12 |
2009-03-17 |
Affymetrix, Inc. |
Nucleic acid labeling methods
|
EP2194147B1
(de)
|
2002-12-04 |
2015-07-22 |
Applied Biosystems, LLC |
Multiplexverstärkung von Polynucleotiden
|
US20080014579A1
(en)
*
|
2003-02-11 |
2008-01-17 |
Affymetrix, Inc. |
Gene expression profiling in colon cancers
|
US7892745B2
(en)
|
2003-04-24 |
2011-02-22 |
Xdx, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
GB0310270D0
(en)
*
|
2003-05-03 |
2003-06-11 |
Univ Edinburgh |
Biomolecular devices
|
EP2327796A1
(de)
|
2003-06-10 |
2011-06-01 |
The Trustees Of Boston University |
Nachweismethoden für Lungenerkrankungen
|
US20040259100A1
(en)
|
2003-06-20 |
2004-12-23 |
Illumina, Inc. |
Methods and compositions for whole genome amplification and genotyping
|
US8131475B2
(en)
|
2003-09-03 |
2012-03-06 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Methods for identifying, diagnosing, and predicting survival of lymphomas
|
EP2157524A3
(de)
|
2003-09-03 |
2010-12-08 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Verfahren zur Identifizierung und Diagnose von sowie vohersage des Überlebens bei Lymphomen
|
WO2005054516A2
(en)
|
2003-11-26 |
2005-06-16 |
Advandx, Inc. |
Peptide nucleic acid probes for analysis of certain staphylococcus species
|
EP1564306B1
(de)
|
2004-02-17 |
2013-08-07 |
Affymetrix, Inc. |
Verfahren zur Fragmentierung und Markierung von DNS
|
WO2005082110A2
(en)
*
|
2004-02-26 |
2005-09-09 |
Illumina Inc. |
Haplotype markers for diagnosing susceptibility to immunological conditions
|
KR20080075045A
(ko)
|
2004-03-24 |
2008-08-13 |
트리패스 이미징, 인코포레이티드 |
자궁경부 질환의 검사 방법 및 조성물
|
WO2006029184A2
(en)
*
|
2004-09-08 |
2006-03-16 |
Expression Diagnostics, Inc. |
Genes useful for diagnosing and monitoring inflammation related disorders
|
EP1647600A3
(de)
|
2004-09-17 |
2006-06-28 |
Affymetrix, Inc. (A US Entity) |
Verfahren zur Kennzeichnung von biologischen Proben durch Hinzufügung von Nukleinsäre "bar-code" Markierungen
|
US20060073511A1
(en)
|
2004-10-05 |
2006-04-06 |
Affymetrix, Inc. |
Methods for amplifying and analyzing nucleic acids
|
US7682782B2
(en)
|
2004-10-29 |
2010-03-23 |
Affymetrix, Inc. |
System, method, and product for multiple wavelength detection using single source excitation
|
EP1652580A1
(de)
|
2004-10-29 |
2006-05-03 |
Affymetrix, Inc. |
Mikroarray mit hohem Durchsatz, Arrayanordnung und Herstellungsverfahren für Arrays
|
US7647186B2
(en)
*
|
2004-12-07 |
2010-01-12 |
Illumina, Inc. |
Oligonucleotide ordering system
|
JP2008537120A
(ja)
|
2005-04-14 |
2008-09-11 |
ザ トラスティーズ オブ ボストン ユニバーシティ |
分類予測を使用した肺障害についての診断
|
EP1885889A4
(de)
*
|
2005-05-11 |
2010-01-20 |
Expression Diagnostics Inc |
Verfahren zur überwachung des betriebsstatus von transplantaten über genlisten
|
US20070072175A1
(en)
*
|
2005-05-13 |
2007-03-29 |
Biogen Idec Ma Inc. |
Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
|
ES2429564T3
(es)
|
2005-05-18 |
2013-11-15 |
Novartis Ag |
Procedimientos para el diagnóstico y tratamiento de enfermedades que tienen un componente autoinmune y/o inflamatorio
|
WO2006138257A2
(en)
|
2005-06-15 |
2006-12-28 |
Callida Genomics, Inc. |
Single molecule arrays for genetic and chemical analysis
|
US20070054168A1
(en)
*
|
2005-09-06 |
2007-03-08 |
Hao Chang |
Zinc/air cell
|
EP1941057A4
(de)
*
|
2005-10-07 |
2009-11-11 |
Baylor Res Inst |
Diagnose des systemischen ausbruchs juveniler idiopathischer arthritis über blutleukozyten-mikroarrayanalyse
|
US7329860B2
(en)
|
2005-11-23 |
2008-02-12 |
Illumina, Inc. |
Confocal imaging methods and apparatus
|
US7634363B2
(en)
*
|
2005-12-07 |
2009-12-15 |
Affymetrix, Inc. |
Methods for high throughput genotyping
|
US20090215055A1
(en)
*
|
2005-12-13 |
2009-08-27 |
Erasmus University Medical Center Rotterdam |
Genetic Brain Tumor Markers
|
US20070161031A1
(en)
*
|
2005-12-16 |
2007-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Functional arrays for high throughput characterization of gene expression regulatory elements
|
EP1989326A4
(de)
|
2006-01-17 |
2009-09-30 |
Health Research Inc |
Heteroduplex-verfolgungstest
|
US20070212721A1
(en)
|
2006-01-27 |
2007-09-13 |
Tripath Imaging, Inc. |
Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
|
WO2007103541A2
(en)
|
2006-03-09 |
2007-09-13 |
The Trustees Of Boston University |
Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
|
WO2007109376A2
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Anti-tumor cell antigen antibody therapeutics
|
US7914988B1
(en)
|
2006-03-31 |
2011-03-29 |
Illumina, Inc. |
Gene expression profiles to predict relapse of prostate cancer
|
CA2648580A1
(en)
*
|
2006-04-07 |
2008-05-02 |
Xdx, Inc. |
Steroid responsive nucleic acid expression and prediction of disease activity
|
US20070259346A1
(en)
*
|
2006-05-03 |
2007-11-08 |
Agilent Technologies, Inc. |
Analysis of arrays
|
US20080058218A1
(en)
*
|
2006-05-03 |
2008-03-06 |
Gordon David B |
Arrays of compound probes and methods using the same
|
EP2057465A4
(de)
|
2006-08-09 |
2010-04-21 |
Homestead Clinical Corp |
Organspezifische proteine und anwendungsverfahren dafür
|
WO2008021431A2
(en)
*
|
2006-08-14 |
2008-02-21 |
Xdx, Inc. |
Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
|
WO2008048986A2
(en)
*
|
2006-10-17 |
2008-04-24 |
Children's Hospital Medical Center |
Gene array technique for predicting response in inflammatory bowel diseases
|
US9845494B2
(en)
|
2006-10-18 |
2017-12-19 |
Affymetrix, Inc. |
Enzymatic methods for genotyping on arrays
|
CA2704288A1
(en)
|
2006-11-03 |
2008-08-21 |
Baylor Research Institute |
Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis
|
US8148067B2
(en)
*
|
2006-11-09 |
2012-04-03 |
Xdx, Inc. |
Methods for diagnosing and monitoring the status of systemic lupus erythematosus
|
US20080242560A1
(en)
*
|
2006-11-21 |
2008-10-02 |
Gunderson Kevin L |
Methods for generating amplified nucleic acid arrays
|
US8293684B2
(en)
*
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
EP2135080A4
(de)
*
|
2007-03-08 |
2010-12-01 |
Switchgear Genomics |
Funktionelle arrays zur charakterisierung mit hohem durchsatz von regulatorischen elementen in nichttranslatierten bereichen von genen
|
US20080241831A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Jian-Bing Fan |
Methods for detecting small RNA species
|
WO2008127710A2
(en)
|
2007-04-13 |
2008-10-23 |
Dana Farber Cancer Institute |
Methods for treating cancer resistant to erbb therapeutics
|
US8200440B2
(en)
|
2007-05-18 |
2012-06-12 |
Affymetrix, Inc. |
System, method, and computer software product for genotype determination using probe array data
|
WO2009113779A2
(ko)
|
2008-03-11 |
2009-09-17 |
국립암센터 |
Snp 어레이를 이용한 염색체, 유전자, 또는 특정 뉴클레오티드 서열의 카피 수 측정방법
|
GB0809069D0
(en)
|
2008-05-19 |
2008-06-25 |
Univ Leuven Kath |
Gene signatures
|
US8039817B2
(en)
|
2008-05-05 |
2011-10-18 |
Illumina, Inc. |
Compensator for multiple surface imaging
|
EP2294214A2
(de)
*
|
2008-05-07 |
2011-03-16 |
Illumina, Inc. |
Zusammensetzungen und verfahren zur bereitstellung von substanzen an und aus einem array
|
JP2009268665A
(ja)
*
|
2008-05-07 |
2009-11-19 |
Canon Inc |
吸入装置
|
EP2664679B1
(de)
|
2008-05-30 |
2017-11-08 |
The University of North Carolina At Chapel Hill |
Genexpressionsprofile zur Vorhersage des Ausgangs von Brustkrebserkrankungen
|
US20110195064A1
(en)
|
2008-06-06 |
2011-08-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv |
Survival predictor for diffuse large b cell lymphoma
|
US20100087325A1
(en)
*
|
2008-10-07 |
2010-04-08 |
Illumina, Inc. |
Biological sample temperature control system and method
|
EP2340314B8
(de)
|
2008-10-22 |
2015-02-18 |
Illumina, Inc. |
Erhaltung von informationen in verbindung mit genomischer dna-methylierung
|
EP3722810A3
(de)
|
2009-02-11 |
2021-01-13 |
Caris MPI, Inc. |
Molekulare profilierung von tumoren
|
EP3255146B1
(de)
|
2009-03-16 |
2019-05-15 |
Pangu Biopharma Limited |
Zusammensetzungen und verfahren mit histidyl-trna-synthetase-spleissvarianten mit nicht-kanonischen biologischen aktivitäten
|
US20100310576A1
(en)
|
2009-03-31 |
2010-12-09 |
Adams Ryan A |
COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
|
US8815779B2
(en)
|
2009-09-16 |
2014-08-26 |
SwitchGear Genomics, Inc. |
Transcription biomarkers of biological responses and methods
|
EP2488873B1
(de)
|
2009-10-16 |
2015-08-05 |
Novartis AG |
Biomarker für pharmakodynamische tumorreaktionen
|
CA2779223A1
(en)
|
2009-10-27 |
2011-05-12 |
Caris Mpi, Inc. |
Molecular profiling for personalized medicine
|
US20120282276A1
(en)
|
2009-11-05 |
2012-11-08 |
The Regents Of The University Of Michigan |
Biomarkers predictive of progression of fibrosis
|
US8501122B2
(en)
|
2009-12-08 |
2013-08-06 |
Affymetrix, Inc. |
Manufacturing and processing polymer arrays
|
US8835358B2
(en)
|
2009-12-15 |
2014-09-16 |
Cellular Research, Inc. |
Digital counting of individual molecules by stochastic attachment of diverse labels
|
AU2010336392B2
(en)
|
2009-12-23 |
2014-01-23 |
Hill's Pet Nutrition, Inc. |
Compositions and methods for diagnosing and treating kidney disorders in a canine
|
ES2596655T3
(es)
|
2010-02-01 |
2017-01-11 |
Illumina Inc. |
Procedimientos de enfoque y sistemas y conjuntos ópticos que usan los mismos
|
JP2013519869A
(ja)
|
2010-02-10 |
2013-05-30 |
ノバルティス アーゲー |
筋肉成長のための方法および化合物
|
WO2011112465A1
(en)
|
2010-03-06 |
2011-09-15 |
Illumina, Inc. |
Systems, methods, and apparatuses for detecting optical signals from a sample
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
JP6066900B2
(ja)
|
2010-04-26 |
2017-01-25 |
エータイアー ファーマ, インコーポレイテッド |
システイニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
CN103096911B
(zh)
|
2010-04-27 |
2018-05-29 |
Atyr 医药公司 |
与异亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
US8993723B2
(en)
|
2010-04-28 |
2015-03-31 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases
|
CA2797374C
(en)
|
2010-04-29 |
2021-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
|
AU2011248457B2
(en)
|
2010-04-29 |
2017-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
|
EP2566515B1
(de)
|
2010-05-03 |
2017-08-02 |
aTyr Pharma, Inc. |
Innovative entdeckung von therapeutischen und diagnostischen mitteln sowie antikörperzusammensetzungen im zusammenhang mit proteinfragmenten von arginyl-trna-synthetasen
|
AU2011248230B2
(en)
|
2010-05-03 |
2016-10-06 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-tRNA synthetases
|
ES2623805T3
(es)
|
2010-05-03 |
2017-07-12 |
Atyr Pharma, Inc. |
Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de fenilalanil-alfa-ARNt sintetasas
|
JP6008844B2
(ja)
|
2010-05-04 |
2016-10-19 |
エータイアー ファーマ, インコーポレイテッド |
p38MULTI−tRNA合成酵素複合体のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
JP6396656B2
(ja)
|
2010-05-14 |
2018-09-26 |
エータイアー ファーマ, インコーポレイテッド |
フェニルアラニルβtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
US9034598B2
(en)
|
2010-05-17 |
2015-05-19 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
|
JP6046607B2
(ja)
|
2010-05-27 |
2016-12-21 |
エータイアー ファーマ, インコーポレイテッド |
グルタミニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
US8962560B2
(en)
|
2010-06-01 |
2015-02-24 |
Atyr Pharma Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases
|
CN107898791A
(zh)
|
2010-06-03 |
2018-04-13 |
药品循环有限责任公司 |
布鲁顿酪氨酸激酶(btk)抑制剂的应用
|
JP2013529089A
(ja)
|
2010-06-07 |
2013-07-18 |
エフ.ホフマン−ラ ロシュ アーゲー |
インターロイキン−6受容体を阻害するモノクローナル抗体による薬剤治療に対する応答を予測するための遺伝子発現マーカー
|
WO2011159942A1
(en)
|
2010-06-18 |
2011-12-22 |
Illumina, Inc. |
Conformational probes and methods for sequencing nucleic acids
|
CN103118695B
(zh)
|
2010-07-12 |
2016-08-03 |
Atyr医药公司 |
与甘氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
|
CN103167876B
(zh)
|
2010-08-12 |
2016-08-31 |
菲特治疗公司 |
改进的造血干细胞和祖细胞疗法
|
US9029506B2
(en)
|
2010-08-25 |
2015-05-12 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-tRNA synthetases
|
WO2012050920A1
(en)
|
2010-09-29 |
2012-04-19 |
Illumina, Inc. |
Compositions and methods for sequencing nucleic acids
|
EP2633069B1
(de)
|
2010-10-26 |
2015-07-01 |
Illumina, Inc. |
Sequenzierungsverfahren
|
JP6163104B2
(ja)
|
2010-11-15 |
2017-07-12 |
アクセラレイテッド・バイオサイエンシズ・コーポレーション |
ヒト・トロホブラスト幹細胞からの神経幹細胞の生成
|
CA2819378A1
(en)
|
2010-12-02 |
2012-06-07 |
Katholieke Universiteit Leuven, K.U.Leuven R&D |
Irak-related interventions and diagnosis
|
US8951781B2
(en)
|
2011-01-10 |
2015-02-10 |
Illumina, Inc. |
Systems, methods, and apparatuses to image a sample for biological or chemical analysis
|
JP5808825B2
(ja)
|
2011-02-24 |
2015-11-10 |
ヒルズ・ペット・ニュートリシャン・インコーポレーテッド |
ネコの腎障害を診断および治療する組成物および方法
|
MX358408B
(es)
|
2011-03-02 |
2018-08-20 |
Berg Llc |
Ensayos interrogatorios basados en celulas y usos de los mismos.
|
WO2012119077A1
(en)
|
2011-03-02 |
2012-09-07 |
Morphotek Inc. |
Co -administration of eribulin and farletuzumab for the treatment of breast cancer
|
CA2830240A1
(en)
|
2011-03-15 |
2012-09-20 |
The University Of North Carolina At Chapell Hill |
Methods of treating breast cancer with anthracycline therapy
|
JP2014509515A
(ja)
|
2011-03-18 |
2014-04-21 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
エリブリンに対する応答を予測するための方法及び組成物
|
US9777332B2
(en)
|
2011-03-31 |
2017-10-03 |
St. Jude Children's Research Hospital |
Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia
|
WO2012170936A2
(en)
|
2011-06-09 |
2012-12-13 |
Illumina, Inc. |
Patterned flow-cells useful for nucleic acid analysis
|
BR112013032354A2
(pt)
|
2011-06-15 |
2017-01-03 |
Hills Pet Nutrition Inc |
Composições e métodos para diagnóstico e monitoração de hipertireoidismo em um felino
|
AU2012328662B2
(en)
|
2011-10-28 |
2015-12-17 |
Illumina, Inc. |
Microarray fabrication system and method
|
EP2786156A2
(de)
|
2011-11-30 |
2014-10-08 |
AbbVie Deutschland GmbH & Co KG |
Verfahren und zusammensetzungen zur bestimmung des ansprechens auf eine behandlung mit einem tnf-alpha-hemmer
|
EP2794649B1
(de)
|
2011-12-19 |
2016-04-27 |
Hill's Pet Nutrition, Inc. |
Zusammensetzungen und verfahren zur diagnose von schilddrüsenüberfunktion bei haustieren
|
RU2659423C2
(ru)
|
2012-02-16 |
2018-07-02 |
ЭйТИР ФАРМА, ИНК. |
ГИСТИДИЛ-тРНК-СИНТЕТАЗЫ ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ И ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ
|
WO2013123125A1
(en)
|
2012-02-17 |
2013-08-22 |
President And Fellows Of Harvard College |
Assembly of nucleic acid sequences in emulsions
|
ES2663234T3
(es)
|
2012-02-27 |
2018-04-11 |
Cellular Research, Inc |
Composiciones y kits para recuento molecular
|
EP2820174B1
(de)
|
2012-02-27 |
2019-12-25 |
The University of North Carolina at Chapel Hill |
Verfahren und verwendung für molekulare tags
|
SG10201608234UA
(en)
|
2012-04-02 |
2016-11-29 |
Berg Llc |
Interrogatory cell-based assays and uses thereof
|
EP2834371B1
(de)
|
2012-04-05 |
2019-01-09 |
The Regents of The University of California |
Genexpressionspaneel für brustkrebsprognose
|
MX369628B
(es)
|
2012-05-22 |
2019-11-14 |
Nanostring Technologies Inc |
Genes nano46 y metodos para predecir el resultado del cancer de mama.
|
KR20150032340A
(ko)
|
2012-07-24 |
2015-03-25 |
파마시클릭스, 인코포레이티드 |
브루톤 티로신 키나제(btk)의 억제제에 대한 내성과 관련된 돌연변이
|
CA2881823C
(en)
|
2012-08-20 |
2019-06-11 |
Illumina, Inc. |
Method and system for fluorescence lifetime based sequencing
|
NZ709167A
(en)
|
2012-11-27 |
2020-03-27 |
Univ Pontificia Catolica Chile |
Compositions and methods for diagnosing thyroid tumors
|
US9457053B2
(en)
|
2012-11-30 |
2016-10-04 |
Accelerated Biosciences Corp. |
Methods of differentiating stem cells by modulating MIR-124
|
BR112015017403A2
(pt)
|
2013-01-21 |
2017-11-21 |
Abbvie Inc |
biomarcadores de terapia de combinação de anti-tnf e anti-il17 para doença inflamatória
|
JP6416793B2
(ja)
|
2013-02-28 |
2018-10-31 |
カプリオン プロテオミクス インコーポレーテッド |
結核のバイオマーカー及びその使用
|
GB2584364A
(en)
|
2013-03-15 |
2020-12-02 |
Abvitro Llc |
Single cell bar-coding for antibody discovery
|
ES2751402T3
(es)
|
2013-03-27 |
2020-03-31 |
Bluegnome Ltd |
Evaluación del riesgo de aneuploidía
|
EP3842542A1
(de)
|
2013-08-28 |
2021-06-30 |
Becton, Dickinson and Company |
Massiv parallele einzelzellanalyse
|
JP2016537010A
(ja)
|
2013-09-09 |
2016-12-01 |
ブリティッシュ コロンビア キャンサー エージェンシー ブランチ |
予後を予測するための方法及びキット、並びに、放射線照射療法を用いた乳癌の治療方法及びキット
|
US9352315B2
(en)
|
2013-09-27 |
2016-05-31 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Method to produce chemical pattern in micro-fluidic structure
|
AU2014329547B2
(en)
|
2013-10-02 |
2019-05-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Wnt compositions and methods for purification
|
AU2014346788B8
(en)
|
2013-11-06 |
2021-01-28 |
Arizona Board Of Regents On Behalf Of The Unviersity Of Arizona |
Method for subtyping lymphoma types by means of expression profiling
|
CN112322735A
(zh)
|
2014-01-16 |
2021-02-05 |
启迪公司 |
用于***癌复发的预后的基因表达面板
|
US10704097B2
(en)
|
2014-02-27 |
2020-07-07 |
Katholieke Universiteit Leuven |
Oxidative stress and cardiovascular disease events
|
WO2015127517A1
(en)
|
2014-02-27 |
2015-09-03 |
Katholieke Universiteit Leuven |
Oxidative stress and cardiovascular disease events
|
US9885086B2
(en)
|
2014-03-20 |
2018-02-06 |
Pharmacyclics Llc |
Phospholipase C gamma 2 and resistance associated mutations
|
JP2017516501A
(ja)
|
2014-05-30 |
2017-06-22 |
ジーンセントリック ダイアグノスティクス, インコーポレイテッド |
肺がんのタイピング法
|
US20160000936A1
(en)
|
2014-06-10 |
2016-01-07 |
Abbvie Inc. |
Biomarkers for inflammatory disease and methods of using same
|
EP3194593B1
(de)
|
2014-09-15 |
2019-02-06 |
AbVitro LLC |
Nukleotidbibliotheksequenzierung mit hohem durchsatz
|
CA3148687A1
(en)
|
2014-11-26 |
2016-06-02 |
Accelerated Biosciences Corp. |
Induced hepatocytes and uses thereof
|
EP3604556A1
(de)
|
2014-12-12 |
2020-02-05 |
Medivation Prostate Therapeutics LLC |
Verfahren zur vorhersage der reaktion auf brustkrebstherapeutika und verfahren zur behandlung von brustkrebs
|
CN107208057A
(zh)
|
2014-12-19 |
2017-09-26 |
Vrije布鲁塞尔大学 |
哺乳动物卵丘***复合体的体外成熟
|
WO2016130572A2
(en)
|
2015-02-10 |
2016-08-18 |
Dana-Farber Cancer Institute, Inc. |
Methods of determining levels of exposure to radiation and uses thereof
|
EP3274692B1
(de)
|
2015-03-24 |
2022-08-10 |
Illumina, Inc. |
Verfahren zur bildgebung von proben zur biologischen oder chemischen analyse
|
AU2016271049B9
(en)
|
2015-05-29 |
2019-07-18 |
Illumina, Inc. |
Sample carrier and assay system for conducting designated reactions
|
JP6923509B2
(ja)
|
2015-07-28 |
2021-08-18 |
オトノミ—,インク. |
切断型のtrkbおよびtrkcのアンタゴニストを使用する処置
|
US10976334B2
(en)
|
2015-08-24 |
2021-04-13 |
Illumina, Inc. |
In-line pressure accumulator and flow-control system for biological or chemical assays
|
WO2018057051A1
(en)
|
2016-09-24 |
2018-03-29 |
Abvitro Llc |
Affinity-oligonucleotide conjugates and uses thereof
|
KR20180085717A
(ko)
|
2015-09-24 |
2018-07-27 |
에이비비트로, 엘엘씨 |
친화성-올리고뉴클레오타이드 콘쥬게이트 및 그것의 사용
|
AU2016326734B2
(en)
|
2015-09-25 |
2022-07-07 |
Abvitro Llc |
High throughput process for T cell receptor target identification of natively-paired T cell receptor sequences
|
CN108138226B
(zh)
|
2015-10-18 |
2022-02-11 |
阿费梅特里克斯公司 |
单核苷酸多态性和***缺失的多等位基因基因分型
|
AU2017246334C1
(en)
|
2016-04-04 |
2022-11-17 |
Sinopia Biosciences, Inc. |
Treating extrapyramidal syndrome using Trapidil
|
US11725248B2
(en)
|
2016-04-20 |
2023-08-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Evaluation of mantle cell lymphoma and methods related thereto
|
WO2017201164A1
(en)
|
2016-05-17 |
2017-11-23 |
Genecentric Diagnostics, Inc. |
Methods for subtyping of lung squamous cell carcinoma
|
EP3458612B1
(de)
|
2016-05-17 |
2023-11-15 |
Genecentric Therapeutics, Inc. |
Verfahren zur subtypisierung von lungenadenokarzinomen
|
EP3260552A1
(de)
|
2016-06-20 |
2017-12-27 |
Istituto Europeo di Oncologia (IEO) |
Verfahren und kits mit gensignaturen zur stratifizierung von brustkrebspatienten
|
WO2018013883A1
(en)
|
2016-07-14 |
2018-01-18 |
Caprion Proteomics Inc. |
Biomarkers of latent tuberculosis infection
|
WO2018064116A1
(en)
|
2016-09-28 |
2018-04-05 |
Illumina, Inc. |
Methods and systems for data compression
|
WO2018213803A1
(en)
|
2017-05-19 |
2018-11-22 |
Neon Therapeutics, Inc. |
Immunogenic neoantigen identification
|
EP3638814B8
(de)
|
2017-06-14 |
2023-06-21 |
The United States of America, as Represented by The Secretary, Department of Health and Human Services |
Verfahren zur bestimmung des lymphomtyps
|
WO2018237327A1
(en)
|
2017-06-22 |
2018-12-27 |
Triact Therapeutics, Inc. |
METHODS OF TREATING GLIOBLASTOMA
|
WO2019018764A1
(en)
|
2017-07-21 |
2019-01-24 |
Genecentric Therapeutics, Inc. |
METHODS OF DETERMINING RESPONSE TO PARP INHIBITORS
|
EP3687501A4
(de)
|
2017-09-29 |
2021-06-23 |
Triact Therapeutics, Inc. |
Iniparib-formulierungen und verwendungen davon
|
ES2960914T3
(es)
|
2018-03-16 |
2024-03-07 |
Gopath Laboratories Llc |
Métodos para la detección personalizada de la reaparición del cáncer o de la metástasis y/o evaluación de la respuesta al tratamiento
|
EP3847261A1
(de)
|
2018-09-05 |
2021-07-14 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
Verfahren zum engineering von synthetischer cis-regulierender dna
|
US20210388449A1
(en)
|
2018-10-09 |
2021-12-16 |
Genecentric Therapeutics, Inc. |
Detecting cancer cell of origin
|
WO2020104482A1
(en)
|
2018-11-20 |
2020-05-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting metastatic potential in patients suffering from sdhb-mutated paraganglioma
|
JP7462632B2
(ja)
|
2018-11-30 |
2024-04-05 |
カリス エムピーアイ インコーポレイテッド |
次世代分子プロファイリング
|
EP3956476A1
(de)
|
2019-04-17 |
2022-02-23 |
Igenomix S.L. |
Verbesserte verfahren zur frühdiagnose von uterinen leiomyomen und leiomyosarkomen
|
WO2021112918A1
(en)
|
2019-12-02 |
2021-06-10 |
Caris Mpi, Inc. |
Pan-cancer platinum response predictor
|
EP4121534A1
(de)
|
2020-03-18 |
2023-01-25 |
Alnylam Pharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur behandlung von patienten mit einer heterozygoten alaninglyoxylat-aminotransferase-genvariante (agxt)
|
EP3907301A1
(de)
|
2020-05-08 |
2021-11-10 |
Istituto Europeo di Oncologia S.r.l. |
Methoden und kits zur bestimmung des risikos eines erneuten auftretens von brustkrebs
|
WO2023122758A1
(en)
|
2021-12-22 |
2023-06-29 |
Cornell University |
Prognostic/predictive epigenetic breast cancer signature
|
WO2023122363A1
(en)
|
2021-12-23 |
2023-06-29 |
Illumina Software, Inc. |
Dynamic graphical status summaries for nucelotide sequencing
|
US20230215515A1
(en)
|
2021-12-23 |
2023-07-06 |
Illumina Software, Inc. |
Facilitating secure execution of external workflows for genomic sequencing diagnostics
|
WO2023129764A1
(en)
|
2021-12-29 |
2023-07-06 |
Illumina Software, Inc. |
Automatically switching variant analysis model versions for genomic analysis applications
|
CN115814060A
(zh)
*
|
2022-08-30 |
2023-03-21 |
长春科技学院 |
胸腺素β10在制备修复肝损伤药物中的用途
|